Archives
Press Releases
advertisement
November 9, 2022
- Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes
- AI Clinical Decision Support Tool Predicts Risk of Diabetes Complications
- Walgreens Teams Up with Its Health Corners and Clinic Partners to Expand Access to Complimentary Diabetes Services during Diabetes Awareness Month
- Lilly to begin rollout of Tempo® Personalized Diabetes Management Platform
- LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM
November 1, 2022
October 19, 2022
- Bionic Pancreas Improves Type 1 Diabetes Management in Kids and Adults
- The Global Insulin Syringes Market is expected to grow by $ 408.67 mn during 2022-2026, accelerating at a CAGR of 4.69% during the forecast period
- GlucoTrack to begin R&D for new long-term CGM
- Abbott’s FreeStyle Libre 2 CGM beats fingerstick testing in independent clinical trial
- URGENT: Medical Device Correction – Important Information Regarding the Omnipod DASH® Insulin Management System Bolus Calculator
- Medtronic launches diabetes insights program for MiniMed users
October 5, 2022
- AmideBio Awarded SBIR Phase IIB Grant to Support Pre-Clinical Development of its Long-Acting Stable Glucagon Analog for the Treatment of Hyperinsulinism
- The American Diabetes Association Launches Collaborative Oral Health Campaign with Pacific Dental Services
- Nevro Announces American Association of Clinical Endocrinology Clinical Practice Guideline Has Been Updated to Include High-Frequency 10 kHz Spinal Cord Stimulation to Treat Painful Diabetic Neuropathy
- THE DIABETES LINK LAUNCHES TO HELP YOUNG ADULTS THRIVE WHILE LIVING WITH THE DISEASE
September 28, 2022
- 12-month real-world achievements for Diabeloop’s Automated Insulin Delivery (AID)
- JDRF Announces Launch of global Type 1 Diabetes Index
- Diabeloop’s insulin delivery AI boosts time in range, minimizes hypoglycemia in one-year data
- Helmsley Charitable Trust Announces a Public T1D Exercise Dataset and Request for Proposals
- Dexcom G7 Launch Update – Interview with Dexcom COO Jake Leach at EASD
advertisement
